Friday, May 9, 2025
Home 2024

Yearly Archives: 2024

Biotech News

COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Editor / Curator -
2024 Watch List

We’re in Tampa for the Kentucky Derby.

Editor / Curator -
Institutional Analyst Newsletter

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX).

Editor / Curator -
2024 Watch List

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Editor / Curator -
2024 Watch List

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Launches Vaccine Manufacturing System.

Editor / Curator -
All News

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and...

Editor / Curator -
Mpox

Major Mpox Outbreak in the Democratic Republic of Congo.

Editor / Curator -
All News

Mpox Infections Rise to Almost Double Last Year’s Numbers.

Editor / Curator -
All News

Adding Asia Broadband (AABB) to Speculative Watch List.

Editor / Curator -
123...6Page 2 of 6

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.